- Patent Litigation
- General Litigation
- Complex Commercial and Business Litigation
- Unfair Competition and False Advertising Litigation
- Trade Secret Litigation
- Post Grant Practice
- Inter Partes Review
- Post-Grant Review
- Patent Reissue
- Ex Parte Reexaminations
- Derivation Proceedings
- Pharmaceutical Practice
- Pharmaceutical Litigation
- Life Sciences Practice
- Energy Storage, Batteries, and Materials Practice
- "Super Lawyers," Intellectual Property, Connecticut, 2012, 2016-2018, 2020
- U.S. District Court, Eastern District of Michigan, 2020
- U.S. District Court, District of Massachusetts, 2001
- U.S. District Court, District of Connecticut, 2000
- State of Connecticut, 2000
- Commonwealth of Massachusetts, 1997
- U.S. Patent and Trademark Office, 1997
Western New England University School of Law, J.D., 1997
Massachusetts College of Pharmacy and Allied Health Sciences, B.S., 1992
Andrew Ryan is a partner in Cantor Colburn’s Litigation Practice Group and chairs the firm’s Post Grant Practice. He is a trial lawyer with almost 20 years' experience representing plaintiffs and defendants in patent cases and other intellectual property and complex litigation matters. He also has significant experience in inter partes review (IPR) and other adversarial proceedings in the U.S. Patent and Trademark Office. Andy has experience in a wide variety of industry areas, including electronics and semiconductors, robotics, automotive components, medical devices, pharmaceuticals, and biotechnology. He has participated in and led matters before the U.S. District Courts of CT, MA, NY, NJ, DE, FL, CA, TX, the Patent Trial and Appeals Board (PTAB), the International Trade Commission (ITC), and the U.S. Court of Appeals for the Federal Circuit.
Andy is experienced in the fields of patents, trademarks, trade dress, unfair competition, copyrights and trade secrets. He has represented clients in federal and state court in bench and jury trials, preliminary injunction proceedings, and in appellate matters. Andy's trial experience includes cases involving a variety of technologies, including shape memory alloys, medical stent technology, restorative dental materials, and industrial safety products, including earplugs and protective eye wear.
Partner, Cantor Colburn LLP, 2006-present
Associate, Cantor Colburn LLP, 1999-2006
- June 22, 2021
Supreme Court Requires More Oversight Over PTAB In Arthrex Decision, a Cantor Colburn Client Alert written by Post-Grant Practice Chair Andrew Ryan."The Supreme Court finds that the USPTO Director has ultimate oversight over PTAB decisions .... IPR procedures are expected to remain intact largely as is."
- November 11, 2020
Cantor Colburn's Client Alert addresses the Federal Circuit's decision on establishing venue in Hatch-Waxman suits.
- July 25, 2018
- Legal 500 USA 2018June 4, 2018
Cantor Colburn LLP has been recommended as a Leading Firm by the Legal 500 United States 2018 in Intellectual Property for Patents: prosecution (including re-examination and post-grant proceedings). This is the ninth consecutive year that Cantor Colburn has been recognized for this highly selective honor.
- April 27, 2018
On April 24, 2018, the Supreme Court issued two important decisions in the cases of Oil States Energy Services, LLC v. Greene’s Energy Group, LLC, et al., and SAS Institute Inc. v. Iancu, addressing inter partes review (IPR). Both cases will have a significant impact on IPR proceedings. In sum and as discussed in greater detail in Cantor Colburn's Client Alert, the Court determined that (1) IPR proceedings are indeed constitutional, and (2) the Patent Trial and Appeal Board (PTAB) must address all challenged claims in the final written decision.
- The Connecticut Law TribuneApril 20, 2015
- Law360March 24, 2015
Members of Cantor Colburn's Pharmaceutical IP Services Practice Group co-authored an article on biosimilars entitled "BPCIA: How Long Does The Party Last And Do I Have To Dance?" that appeared in Law360 on March 24, 2015. Leslie-Anne Maxwell, Andrew Ryan, Christopher Potts and Derek Denhart wrote the article which discusses Amgen Inc. v. Sandoz Inc.
- Law360March 20, 2015
Partner Andrew Ryan comments in Law360's March 20, 2015 article on Amgen Inc. v Sandoz Inc., "3 Things To Watch After Sandoz's Biosimilars Win."
- Law360February 4, 2015
Cantor Colburn litigator Andrew Ryan wrote an analysis of the U.S. Court of Appeals for the Federal Circuit first-ever ruling in an appeal from an inter partes review in In re Cuozzo Speed Technologies LLC, published in Law360 on February 4, 2015.
- IP Law 360January 21, 2015
The U.S. Supreme Court on January 20, 2015 cast aside the Federal Circuit's long-standing rule that all district court claim construction rulings must be reviewed anew on appeal. Cantor Colburn litigation partner Andrew Ryan and other litigators tell Law360 why the decision in Teva Pharmaceuticals v. Sandoz is significant.
- The Connecticut Law TribuneDecember 29, 2014
Cantor Colburn Litigation Partner Andrew C. Ryan and Associate Chad A. Dever wrote the article, "A New Era in Intellectual Property Law," published by The Connecticut Law Tribune on December 29, 2014.
- The Connecticut Law TribuneOctober 20, 2014
The 2012 America Invents Act ushered in three new procedures that allow a petitioner to challenge the validity of one or more patent claims after they have been granted by the PTO: inter partes review, post grant review, and covered business method. This article by Cantor Colburn partner and trial attorney Andrew Ryan and litigation associate Chad Dever, Ph.D., examines the new procedures. Ryan chairs the firm's Post Grant Practice Group, one of the first of its kind in the country.
- Law360June 2014
Law360 quoted several attorneys about the Nautilus Inc. v. Biosig Instruments Inc. decision and amongst them was Cantor Colburn’s Andrew C. Ryan.
- Corporate CounselOctober 2013
Cantor Colburn was nationally ranked for patent litigation by Corporate Counsel magazine in its October 2013 issue. Cantor Colburn’s dedicated team of litigation attorneys have decades of experience in presenting technically complex matters for trial in front of judges and juries. A partner participates in every facet of the case, bringing results that count for the client. And at each phase of the litigation, Cantor Colburn seeks practical strategies to achieve a prompt, efficient resolution of the dispute.
- Hartford Business JournalAugust 14, 2012
- IP Law 360October 12, 2011
- Corporate CounselDecember 31, 2010
- Medical Device Patents Infringement and Enforcement: Monitoring, Diligence, Alternatives, Path of EnforcementDecember 5, 2023CLE webinar
Cantor Colburn Partner and Post Grant Chair Andrew C. Ryan will discuss Medical Device Patents Infringement and Enforcement: Monitoring, Diligence, Alternatives, Path of Enforcement, in a live 90-minute premium CLE video webinar with interactive Q&A on Tuesday, December 5, 2023.
- June 15, 2022Iselin, New Jersey
Cantor Colburn partner Andrew C. Ryan will present, "PlasmaCAM, Inc. v. CNCElectronics, LLC - Infringement of licensing" during the annual Joint Patent Practice Continuing Legal Education (JPPCLE) Seminar on June 15, 2022 in Iselin, New Jersey.
- May 2, 2019New York City
Andy Ryan will be a panelist at the Joint Patent Practice CLE on May 2, 2019 in New York City. His panel will be on patents found invalid under Section 112 for lack of written description and enablement, including the cases D Three Enterprises, LLC V. Sunmodo Corporation et al 2017-1909 et al (Fed. Cir.) May 21, 2018 and Trustees of Boston University v. Everlight Electronics Co., LTD, et al, 2016-2576 (Fed. Cir. July 25, 2018). \
- April 29, 2019New York City
Pharmaceutical Litigation Chair Steve Coyle will be a panelist at the Paragraph IV Disputes Conference in New York City, April 29-30, 2019. Cantor Colburn has a dedicated Pharmaceutical Practice Group comprised of experienced litigators, Ph.D. chemists, and patent attorneys expert in other supporting technologies. Also attending from Cantor Colburn are Michael Cantor, Andrew Ryan and Nicholas Geiger.
- April 23, 2018New York City
Cantor Colburn is sponsoring the Paragraph IV Disputes conference in New York City on April 23-25, 2018. Cantor Colburn has a dedicated Pharmaceutical Practice Group comprised of experienced litigators, Ph.D. chemists, and patent attorneys.
- April 21, 2016New York, New York
Andy is a trial lawyer with over a decade of experience representing plaintiffs and defendants in patent cases and other complex litigation matters. He also has significant experience in adversarial proceedings in the Patent and Trademark Office and chairs the firm’s Post Grant Review Practice Group. He regularly counsels clients on adversarial PTO proceedings co-pending with litigation.
American Bar Association
American Intellectual Property Law Association
Connecticut Patent Law Association
Connecticut Bar Association
Intellectual Property Owners Association (IPO)